All Stories

  1. The effects of multitarget kinase inhibitors on glucose, cholesterol, and triglyceride levels
  2. Ultrasound screening for thyroid nodules and cancer in individuals with family history of thyroid cancer: a micro-costing approach
  3. A Reappraisal of Suspicious Sonographic Features of Thyroid Nodules: Shape Is Not an Independent Predictor of Malignancy
  4. Predicting recurrence of thyroid cancer: how to.
  5. Prevalence of Thyroid Nodules and Thyroid Cancer in Individuals with a First-Degree Family History of Non-Medullary Thyroid Cancer: A Cross-Sectional Study Based on Sonographic Screening
  6. Size Doesn't Matter! Is Active Surveillance Feasible for Low-Risk Thyroid Cancers up to 20 mm?
  7. What Is the Risk of Missed Malignancies in the Longterm Follow-up of Thyroid Nodules?
  8. Precision oncology for RET-related tumors
  9. New hope for patients with BRAF V600E-mutant anaplastic thyroid cancer: lights and shadows
  10. The legacy of the COVID-19 pandemics for thyroid cancer patients: towards the application of clinical practice recommendations
  11. Artificial Intelligence for Thyroid Nodule Characterization: Where Are We Standing?
  12. The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment
  13. Is Lenvatinib Better Than Sorafenib as First-Line Treatment of Radioiodine Refractory Differentiated Thyroid Cancers?
  14. Establishment and maintenance of thyroid organoids from human cancer cells
  15. Diagnostic accuracy of ultrasonographic features in detecting thyroid cancer in the transition age: a meta-analysis
  16. Levothyroxine Treatment of Subclinical Hypothyroidism in the Elderly Does Not Improve Hemoglobin Levels
  17. Multimodal Feature Fusion and Knowledge-Driven Learning via Experts Consult for Thyroid Nodule Classification
  18. A Network-Based Analysis of Disease Modules From a Taxonomic Perspective
  19. US-Elastography With Different Techniques for Thyroid Nodule Characterization: Systematic Review and Meta-analysis
  20. 18F–FDG–PET/CT May Reduce Unnecessary Thyroid Surgery in Cytologically Indeterminate Thyroid Nodules
  21. Non-Marked Hypoechogenic Nodules: Multicenter Study on the Thyroid Malignancy Risk Stratification and Accuracy Based on TIRADS Systems Comparison
  22. Supporting Personalized Health Care With Social Media Analytics: An Application to Hypothyroidism
  23. Inappropriate Use of Thyroid Ultrasound Is Common in Clinical Practice
  24. Management of cytologically indeterminate thyroid nodules: <i>primum non nocere</i>
  25. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4)
  26. Preoperative Ultrasonography in the Evaluation of Suspected Familial Non-Medullary Thyroid Cancer: Are We Able to Predict Multifocality and Extrathyroidal Extension?
  27. Integrating categorical and structural proximity in Disease Ontologies
  28. Thyroid Nodule Characterization: How to Assess the Malignancy Risk. Update of the Literature
  29. TIRADS, SRE and SWE in INDETERMINATE thyroid nodule characterization: Which has better diagnostic performance?
  30. Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients
  31. Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer
  32. Molecular analysis of fine-needle aspiration cytology in thyroid disease: where are we?
  33. Selective Use of Radioactive Iodine Therapy for Papillary Thyroid Cancers With Low or Lower-Intermediate Recurrence Risk
  34. The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis
  35. Performance of EU-TIRADS in malignancy risk stratification of thyroid nodules: a meta-analysis
  36. Sonographic Risk Stratification Systems for Thyroid Nodules as Rule-Out Tests in Older Adults
  37. Artificial Intelligence: What Is It and How Can It Expand the Ultrasound Potential in the Future?
  38. Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the Thyroid
  39. Cancer Care During COVID-19 Era: The Quality of Life of Patients With Thyroid Malignancies
  40. Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissue
  41. Contemporary Thyroid Nodule Evaluation and Management
  42. Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?
  43. Risk of Kidney Dysfunction IN Nafld
  44. Fournier's gangrene during lenvatinib treatment: A case report
  45. Computer-aided diagnostic system for thyroid nodule sonographic evaluation outperforms the specificity of less experienced examiners
  46. Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules
  47. Diagnostic Performance of Neck Ultrasonography in the Preoperative Evaluation for Extrathyroidal Extension of Suspicious Thyroid Nodules
  48. Low-risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach
  49. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma
  50. Nodular Thyroid Disease in the Era of Precision Medicine
  51. Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: a systematic review and meta-analysis using histological standard of reference
  52. Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification
  53. Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma?
  54. Taller-Than-Wide Shape: A New Definition Improves the Specificity of TIRADS Systems
  55. Clinically silent thyroid cancers: drop those needles and scalpels!
  56. Comment on: BRAF mutation analysis by ARMS‐PCR refines thyroid nodule management
  57. Screening for differentiated thyroid cancer in selected populations
  58. Thyroid hormone therapy in differentiated thyroid cancer
  59. Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy
  60. SONOGRAPHICALLY ESTIMATED THYROID NODULE MALIGNANCY RISK: STRENGTHS AND LIMITATIONS IN CLINICAL PRACTICE
  61. Molecular defects in thyroid dysgenesis
  62. Prognosis of patients with differentiated thyroid carcinomas having a preoperative cytological report of indeterminate at low or high risk. A multicenter study
  63. Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound
  64. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments
  65. Prospective Evaluation of Semiquantitative Strain Ratio and Quantitative 2D Ultrasound Shear Wave Elastography (SWE) in Association with TIRADS Classification for Thyroid Nodule Characterization
  66. Indeterminate thyroid nodules ( TIR 3A/ TIR 3B) according to the new Italian Reporting System for Thyroid Cytology: a cytomorphological study
  67. Levothyroxine Treatment Increases Mortality in Patients with Heart Failure
  68. Is thyroid nodule location associated with malignancy risk?
  69. IS IT WORTH SUPPRESSING TSH IN LOW- AND INTERMEDIATE-RISK PAPILLARY THYROID CANCER PATIENTS BEFORE THE FIRST DISEASE ASSESSMENT?
  70. A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency
  71. Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: towards the “right” TIRADS
  72. Thyroid nodule recurrence following lobo-isthmectomy: incidence, patient’s characteristics, and risk factors
  73. Sonographically Estimated Risks of Malignancy for Thyroid Nodules Computed with Five Standard Classification Systems: Changes over Time and Their Relation to Malignancy
  74. Follow-up of differentiated thyroid cancer – what should (and what should not) be done
  75. Sonographic presentation of metastases to the thyroid gland: a case-series
  76. The distinctive traits of Follicular thyroid cancer and Hürthle cell cancer
  77. Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies
  78. Lack of association between obesity and aggressiveness of differentiated thyroid cancer
  79. The Diagnosis and management of thyroid nodules
  80. What's new on differentiated thyroid cancer?
  81. The level of agreement between different clinicians in the evaluation of thyroid nodules
  82. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory
  83. 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2)
  84. Temporal Changes in Thyroid Nodule Volume: Lack of Effect on Paranodular Thyroid Tissue Volume
  85. MicroRNA-based molecular classification of papillary thyroid carcinoma
  86. Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up
  87. Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules
  88. Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study
  89. Risk Stratification of Neck Lesions Detected Sonographically During the Follow-Up of Differentiated Thyroid Cancer
  90. Grey-Scale Analysis Improves the Ultrasonographic Evaluation of Thyroid Nodules
  91. Association of Thyroid Diseases with Primary Extra-Thyroidal Malignancies in Women: Results of a Cross-Sectional Study of 6,386 Patients
  92. Influence of Thyrotropin and Thyroid Volume on Basal Serum Calcitonin
  93. A comprehensive score to diagnose Hashimoto’s thyroiditis
  94. Thyroglobulin in Lymph Node Fine-Needle Aspiration Washout
  95. Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine‐needle aspiration cytology
  96. Thyroglobulin in fine-needle aspiration wash-out diagnostic performance: a meta-analysis
  97. Serum calcitonin, thyrotropin, and goiter
  98. Thyroid Function in Infertile Patients Undergoing Assisted Reproduction
  99. Intrinsic factors affecting adequacy of thyroid nodule fine‐needle aspiration cytology
  100. Interpretation of serum calcitonin in patients with chronic autoimmune thyroiditis
  101. Therapy of Hyperthyroidism in Pregnancy and Breastfeeding
  102. Medical Treatment of Hyperthyroidism: State of the Art
  103. Diagnostic Accuracy of rhTSH Test with Neck Ultrasonography in Differentiated Thyroid Cancer Follow-up
  104. Medullary Thyroid Carcinoma and Tuberous Sclerosis